全文获取类型
收费全文 | 40816篇 |
免费 | 16598篇 |
国内免费 | 5篇 |
专业分类
57419篇 |
出版年
2022年 | 196篇 |
2021年 | 569篇 |
2020年 | 2297篇 |
2019年 | 3839篇 |
2018年 | 3996篇 |
2017年 | 4237篇 |
2016年 | 4336篇 |
2015年 | 4477篇 |
2014年 | 4152篇 |
2013年 | 4839篇 |
2012年 | 2617篇 |
2011年 | 2326篇 |
2010年 | 3601篇 |
2009年 | 2293篇 |
2008年 | 1405篇 |
2007年 | 1053篇 |
2006年 | 1034篇 |
2005年 | 1077篇 |
2004年 | 1029篇 |
2003年 | 1072篇 |
2002年 | 1076篇 |
2001年 | 422篇 |
2000年 | 332篇 |
1999年 | 357篇 |
1998年 | 280篇 |
1997年 | 191篇 |
1996年 | 202篇 |
1995年 | 205篇 |
1994年 | 185篇 |
1993年 | 148篇 |
1992年 | 189篇 |
1991年 | 140篇 |
1990年 | 137篇 |
1989年 | 139篇 |
1988年 | 113篇 |
1987年 | 132篇 |
1986年 | 115篇 |
1985年 | 141篇 |
1984年 | 163篇 |
1983年 | 119篇 |
1982年 | 168篇 |
1981年 | 161篇 |
1980年 | 148篇 |
1979年 | 132篇 |
1978年 | 130篇 |
1977年 | 116篇 |
1976年 | 117篇 |
1975年 | 83篇 |
1974年 | 103篇 |
1973年 | 96篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
191.
Thomas P. Brennan Pendar Ardalan Han‐Bo‐Ram Lee Jonathan R. Bakke I‐Kang Ding Michael D. McGehee Stacey F. Bent 《Liver Transplantation》2011,1(6):1169-1175
Functioning quantum dot (QD) sensitized solar cells have been fabricated using the vacuum deposition technique atomic layer deposition (ALD). Utilizing the incubation period of CdS growth by ALD on TiO2, we are able to grow QDs of adjustable size which act as sensitizers for solid‐state QD‐sensitized solar cells (ssQDSSC). The size of QDs, studied with transmission electron microscopy (TEM), varied with the number of ALD cycles from 1‐10 nm. Photovoltaic devices with the QDs were fabricated and characterized using a ssQDSSC device architecture with 2,2',7,7'‐tetrakis‐(N,N‐di‐p methoxyphenylamine) 9,9'‐spirobifluorene (spiro‐OMeTAD) as the solid‐state hole conductor. The ALD approach described here can be applied to fabrication of quantum‐confined structures for a variety of applications, including solar electricity and solar fuels. Because ALD provides the ability to deposit many materials in very high aspect ratio substrates, this work introduces a strategy by which material and optical properties of QD sensitizers may be adjusted not only by the size of the particles but also in the future by the composition. 相似文献
192.
193.
194.
Rosane Ness-Abramof Dan Nabriski Caroline M. Apovian Mark Niven Eliahu Weiss Menachem S. Shapiro Louis Shenkman 《Obesity (Silver Spring, Md.)》2002,10(12):1217-1221
Objective: Reevaluation of the validity of the 1-mg overnight dexamethasone suppression test (ODST) as a screening test for Cushing's syndrome in obese patients. Research Methods and Procedures: Eighty-six obese patients (body mass index, 30 to 53 kg/m2) that were referred to a general endocrine outpatient clinic for evaluation of simple obesity, diabetes mellitus, hypertension, polycystic ovary disease, or pituitary tumor. One milligram dexamethasone was administered orally at 11:00 pm , and serum cortisol levels were measured the following morning between 8:00 am and 9:00 am . Suppression of serum cortisol to <80 nM (3 μg/dL) was chosen as the cut-off point for normal suppression. Patients with serum cortisol levels ≥80 nM were evaluated for Cushing's syndrome. Results: Suppression of morning cortisol levels to <80 nM occurred in 79 of the 86 obese patients. Seven patients had serum cortisol levels higher than 80 nM; five were eventually diagnosed with Cushing's syndrome and two were considered false positive results in view of normal 24-hour free urinary cortisol and normal suppression on a low dose dexamethasone suppression test (0.5 mg of dexamethasone every 6 hours for 2 days). We found a false positive rate of 2.3% for the ODST using a cut-off serum cortisol of 80 nM. Discussion: The ODST is a valid screening test for Cushing's syndrome in the obese population. The false positive rate was 2.3%, even when using a strict cut-off serum cortisol of 80 nM. Abnormal cortisol suppression in obese patients should be investigated and not be considered false positive results. 相似文献
195.
196.
Ahmed I Gesty-Palmer D Drezner MK Luttrell LM 《Molecular endocrinology (Baltimore, Md.)》2003,17(8):1607-1621
Recent data suggest that G protein-coupled receptors (GPCRs), including those for PTH and prostaglandins (PGs), contribute to the proliferation and differentiation of osteoblasts in vivo. To understand how these signals are transduced, we studied activation of the ERK1/2 MAPK cascade in cultures of differentiating TMOb murine osteoblasts. In TMOb cells, stimulation of endogenous Gs/Gq-coupled PTH receptors, Gq-coupled PGF2 alpha receptors, and Gi/Gq-coupled lysophosphatidic acid receptors, but not Gs-coupled PGE2 receptors, caused a rapid 5- to 10-fold increase in ERK1/2 phosphorylation. GPCR-stimulated ERK1/2 activation coincided with increased tyrosine phosphorylation of epidermal growth factor (EGF) receptors and was blocked by the EGF receptor inhibitor, tyrphostin AG1478, and the metalloprotease inhibitor, batimastat, suggesting that the response involved transactivation of EGF receptors through the proteolytic release of an EGF receptor ligand. To further examine the mechanism of PTH-stimulated EGF receptor transactivation, we employed COS-7 cells expressing the rat PTH receptor. Here, stimulation with PTH(1-34) caused proteolysis of hemagglutinin epitope-tagged heparin binding-EGF, increased tyrosine autophosphorylation of EGF receptors, and AG1478-sensitive ERK1/2 activation. When PTH receptor-expressing COS-7 cells were placed in a mixed culture with cells lacking the PTH receptor but expressing a green fluorescent protein-tagged ERK2, stimulation with PTH(1-34) induced phosphorylation of green fluorescent protein-ERK2 that was abolished by either batimastat or tyrphostin AG1478. These data suggest that autocrine/paracrine cross-talk between EGF receptors and Gi- or Gq/11-coupled GPCRs represents the predominant mechanism of GPCR-mediated activation of ERK1/2 in cultured TMOb osteoblasts. 相似文献
197.
198.
Lehmann MH Walter S Ylisastigui L Striebel F Ovod V Geyer M Gluckman JC Erfle V 《Experimental cell research》2006,312(18):3659-3668
Infiltration of human immunodeficiency virus type 1 (HIV-1)-infected and uninfected monocytes/macrophages in organs and tissues is a general phenomenon observed in progression of acquired immunodeficiency syndrome (AIDS). HIV-1 protein Nef is considered as a progression factor in AIDS, and is released from HIV-1-infected cells. Here, we show that extracellular Nef increases migration of monocytes. This effect is (i) concentration-dependent, (ii) reaches the order of magnitude of that induced by formyl-methyonyl-leucyl-proline (fMLP) or CC chemokine ligand 2 (CCL2)/monocyte chemotactic protein (MCP)-1, (iii) inhibited by anti-Nef monoclonal antibodies as well as by heating, and (iv) depends on a concentration gradient of Nef. Further, Nef does not elicit monocytic THP-1 cells to express chemokines such as CCL2, macrophage inhibitory protein-1alpha (CCL3) and macrophage inhibitory protein-1beta (CCL4). These data suggest that extracellular Nef may contribute to disease progression as well as HIV-1 spreading through affecting migration of monocytes. 相似文献
199.
Organic Solar Cells: Following the Morphology Formation In Situ in Printed Active Layers for Organic Solar Cells (Adv. Energy Mater. 1/2016) 下载免费PDF全文
200.
Zhenwen Cui Zhihong Zhong Yong Yang Baofeng Wang Yuhao Sun Qingfang Sun Guo‐yuan Yang Liuguan Bian 《Journal of biochemical and molecular toxicology》2016,30(8):396-403
Free radical damage caused by ferrous iron is involved in the pathogenesis of secondary brain injury after intracerebral hemorrhage (ICH). NF‐E2‐related factor 2 (Nrf2), a major phase II gene regulator that binds to antioxidant response element, represents an important cellular cytoprotective mechanism against oxidative damage. We hypothesized that Nrf2 might protect astrocytes from damage by Fe2+. Therefore, we examined cytotoxicity in primary astrocytes induced by iron overload and evaluated the effects of Fe2+ on Nrf2 expression. The results demonstrated that 24‐h Fe2+ exposure exerted time‐ and concentration‐dependent cytotoxicity in astrocytes. Furthermore, Fe2+ exposure in astrocytes resulted in time‐ and concentration‐dependent increases in Nrf2 expression, which preceded Fe2+ toxicity. Nrf2‐specific siRNA further knocked down Nrf2 levels, resulting in greater Fe2+‐induced astrocyte cytotoxicity. These data indicate that induction of Nrf2 expression could serve as an adaptive self‐defense mechanism, although it is insufficient to completely protect primary astrocytes from Fe2+‐induced neurotoxicity. 相似文献